Division of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.
Veterans Research and Education Foundation, Veterans Affairs Medical Center, Oklahoma City, OK, 73104, USA.
Obes Surg. 2020 Mar;30(3):948-956. doi: 10.1007/s11695-019-04365-7.
Vagal nerve stimulation (VNS) has recently been indicated as a novel method for treating obesity. However, the optimal stimulation parameters were unknown and mechanisms were poorly understood. The aim of this study was to investigate the effects of VNS on food intake and body weight in diet-induced obesity (DIO) rats and its possible mechanism involving autonomic functions and gut hormones.
Ten control rats and 16 DIO rats were chronically implanted with one pair of electrodes in the subdiaphragmatic vagal nerve. VNS with different stimulation parameters and sham-VNS were performed in control rats. In a chronic study, 8 DIO rats were applied with VNS and another 8 DIO rats were treated with sham-VNS for 4 weeks. Food intake, body weight, gastric emptying, heart rate variability (HRV), and gut hormones were evaluated.
In DIO rats, the food intake (p < 0.001) and body weight (p < 0.001) were significantly decreased in the VNS group, compared with the sham-VNS group. VNS decreased the sympathovagal ratio (p = 0.003) and increased vagal activity (p = 0.032) assessed from the spectral analysis of HRV. It also increased plasma levels of glucagon-like peptide-1 (p = 0.012), polypeptide YY (p = 0.008), and pancreatic polypeptide (p = 0.008) in DIO rats. Physiologically, VNS delayed solid gastric emptying (p < 0.001) and increased gastric volume (p = 0.004).
VNS with appropriate parameters reduced food intake and body weight by delaying gastric emptying mediated via the enhancement of vagal activity and release of anorexigenic hormones.
迷走神经刺激(VNS)最近被认为是治疗肥胖的一种新方法。然而,最佳刺激参数尚不清楚,其机制也知之甚少。本研究旨在探讨 VNS 对饮食诱导肥胖(DIO)大鼠摄食和体重的影响及其可能涉及自主功能和肠道激素的机制。
将一对电极慢性植入十只对照大鼠和十六只 DIO 大鼠的膈下迷走神经。在对照大鼠中进行不同刺激参数的 VNS 和假 VNS。在一项慢性研究中,八只 DIO 大鼠接受 VNS 治疗,另八只 DIO 大鼠接受假 VNS 治疗 4 周。评估摄食量、体重、胃排空、心率变异性(HRV)和肠道激素。
与假 VNS 组相比,DIO 大鼠的摄食量(p<0.001)和体重(p<0.001)均显著降低。VNS 降低了交感神经与迷走神经比值(p=0.003),增加了 HRV 频谱分析评估的迷走神经活性(p=0.032)。它还增加了 DIO 大鼠血浆中胰高血糖素样肽-1(p=0.012)、多肽 YY(p=0.008)和胰多肽(p=0.008)的水平。在生理上,VNS 延迟了固体胃排空(p<0.001)并增加了胃容量(p=0.004)。
适当参数的 VNS 通过增强迷走神经活性和释放厌食激素来延迟胃排空,从而减少摄食量和体重。